Last updated 2026-08-22
Total raised
—
Stage
—
Founded
2015
Headcount
—
HQ
null, Israel
Sector
Biotechnology
About
Tete Pharma is developing an innovative anti-angiogenesis cancer drug.
Q&A
- What is Tete Pharma Ltd.'s primary focus?
- Tete Pharma Ltd. is developing an innovative anti-angiogenesis cancer drug.
- When was Tete Pharma Ltd. founded?
- Tete Pharma Ltd. was founded in 2015.
- What sector does Tete Pharma Ltd. operate in?
- Tete Pharma Ltd. operates primarily in the Biotechnology sector, with a focus on Pharmaceuticals.
- What specific technology is Tete Pharma Ltd. utilizing?
- Tete Pharma Ltd. is utilizing anti-angiogenesis technology in its drug discovery efforts.
- What is the target market for Tete Pharma Ltd.'s drug?
- The target market for Tete Pharma Ltd.'s drug is Oncology.
- Where is Tete Pharma Ltd. headquartered?
- Tete Pharma Ltd. is headquartered in Israel.
Sectors & technology
Primary sector
Biotechnology
Technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | tetepharma.com |
|---|
Identifiers & details
| Founded | 2015 |
|---|